AN2 Therapeutics (ANTX) Earnings Date & Reports

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

Industry: #Managed Health Care

Get AI intraday signals

A.I. Advisor

published Earnings

ANTX is expected to report earnings to -25 cents per share on May 07

AN2 Therapeutics ANTX Stock Earnings Reports

Q1'25

Est.

$-0.25

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

Q1'24

Beat

by $0.06

The last earnings report on March 25 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 65.58K shares outstanding, the current market capitalization sits at 37.92M.

View a ticker or compare two or three

Compare

ANTX